FI941832A - Menetelmiä NMR:llä havaittavien ksenobioottisten yhdisteiden in vivo määrittämiseksi - Google Patents

Menetelmiä NMR:llä havaittavien ksenobioottisten yhdisteiden in vivo määrittämiseksi Download PDF

Info

Publication number
FI941832A
FI941832A FI941832A FI941832A FI941832A FI 941832 A FI941832 A FI 941832A FI 941832 A FI941832 A FI 941832A FI 941832 A FI941832 A FI 941832A FI 941832 A FI941832 A FI 941832A
Authority
FI
Finland
Prior art keywords
nmr
concentration
methods
subject
xenobiotic compounds
Prior art date
Application number
FI941832A
Other languages
English (en)
Swedish (sv)
Other versions
FI941832A0 (fi
Inventor
Michael F Tweedle
Harry William Strauss
Adrian D Nunn
Original Assignee
Bristol Meyrs Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Meyrs Squibb Company filed Critical Bristol Meyrs Squibb Company
Publication of FI941832A0 publication Critical patent/FI941832A0/fi
Publication of FI941832A publication Critical patent/FI941832A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/448—Relaxometry, i.e. quantification of relaxation times or spin density
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
FI941832A 1993-04-23 1994-04-20 Menetelmiä NMR:llä havaittavien ksenobioottisten yhdisteiden in vivo määrittämiseksi FI941832A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/052,959 US5468467A (en) 1993-04-23 1993-04-23 Methods for the in vivo measurement of the concentration of non-imaging nmr-detectable xenobiotic compounds

Publications (2)

Publication Number Publication Date
FI941832A0 FI941832A0 (fi) 1994-04-20
FI941832A true FI941832A (fi) 1994-10-24

Family

ID=21981033

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941832A FI941832A (fi) 1993-04-23 1994-04-20 Menetelmiä NMR:llä havaittavien ksenobioottisten yhdisteiden in vivo määrittämiseksi

Country Status (15)

Country Link
US (2) US5468467A (fi)
EP (1) EP0621491B1 (fi)
JP (1) JPH07374A (fi)
KR (1) KR100359898B1 (fi)
CN (1) CN1094938A (fi)
AT (1) ATE221208T1 (fi)
AU (1) AU6061394A (fi)
CA (1) CA2119345C (fi)
CZ (1) CZ89894A3 (fi)
DE (1) DE69431016T2 (fi)
FI (1) FI941832A (fi)
HU (1) HUT69795A (fi)
IL (1) IL109115A (fi)
NO (1) NO941485L (fi)
ZA (1) ZA942781B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753207A (en) * 1995-08-21 1998-05-19 Beth Israel Deaconess Medical Center, Inc. Use of paramagnetic compounds to measure temperature and pH in vivo
US6319678B1 (en) * 1998-06-26 2001-11-20 Panvera Corporation Process for glucuronidation screening
US20040146847A1 (en) * 1998-12-07 2004-07-29 Trubetskoy Olga V. Process for glucuronidation screening
US6440389B1 (en) 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
DE10230877A1 (de) * 2002-07-09 2004-02-12 Siemens Ag Kernspintomographiegerät mit einer Einrichtung zur graphischen Planung Kontrastmittel-gestützter angiographischer Messungen
AU2003214900A1 (en) * 2003-01-23 2004-08-23 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring intravenous (iv) drug concentration using exhaled breath
US7939058B2 (en) * 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
US20080085563A1 (en) * 2006-10-10 2008-04-10 Idexx Laboratories, Inc. Detection of Gadolinium Chelates
US20080085562A1 (en) * 2006-10-10 2008-04-10 Idexx Laboratories, Inc. Detection of gadolinium chelates
KR100973063B1 (ko) * 2008-11-11 2010-07-29 경희대학교 산학협력단 층상 가돌리늄 히드록사이드 및 그를 포함하는 ｍｒｉ 조영제
JP5971677B2 (ja) * 2010-11-26 2016-08-17 東芝メディカルシステムズ株式会社 磁気共鳴診断装置、および、磁気共鳴スペクトロスコピーのデータ収集方法
WO2013118115A1 (en) 2012-02-08 2013-08-15 Anatech Advanced Nmr Algorithms Technologies Ltd Apparatus and method for non-invasive measurement of blood parameters
MX2014014086A (es) * 2012-05-23 2015-01-26 Genentech Inc Metodo de seleccion para agentes terapeuticos.
CN103217449B (zh) * 2013-03-26 2016-02-24 南昌大学 一种基于顺磁纳米Fe-Ni合金探针间接富集的NMR食源性致病菌快速检测方法
CN103217530B (zh) * 2013-03-26 2015-01-28 南昌大学 一种基于顺磁纳米Fe-Co合金探针间接富集的NMR食源性致病菌快速检测方法
WO2015070872A1 (en) * 2013-11-13 2015-05-21 Nanonord A/S A method for quantitative determination of nitrogen in an aqueous fluid
FR3039767B1 (fr) * 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
US11406721B2 (en) 2016-02-22 2022-08-09 The Regents Of The University Of California Compositions and methods for imaging cell populations
WO2023234979A2 (en) * 2021-12-20 2023-12-07 The Regents Of The University Of California High field magnetometry with hyperpolarized nuclear spins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49103693A (fi) * 1973-02-02 1974-10-01
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4837604A (en) * 1986-04-18 1989-06-06 Hypres, Inc. Femtosecond three-terminal switch and vertical tunnel junction
US4875486A (en) * 1986-09-04 1989-10-24 Advanced Techtronics, Inc. Instrument and method for non-invasive in vivo testing for body fluid constituents
IE61448B1 (en) * 1987-06-23 1994-11-02 Hafslund Nycomed Innovation Improvements in and relating to magnetic resonance imaging
US5234680A (en) * 1989-07-31 1993-08-10 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI
US5236694A (en) * 1990-02-21 1993-08-17 The Board Of Regents, The University Of Texas System 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
US5100646A (en) * 1990-07-25 1992-03-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services NMR glomerular filtration test
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
US5250284A (en) * 1991-10-15 1993-10-05 Arnon Krongrad Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc

Also Published As

Publication number Publication date
JPH07374A (ja) 1995-01-06
FI941832A0 (fi) 1994-04-20
KR940023442A (ko) 1994-11-17
CZ89894A3 (en) 1995-02-15
CN1094938A (zh) 1994-11-16
US5603917A (en) 1997-02-18
ZA942781B (en) 1995-01-05
NO941485D0 (no) 1994-04-22
US5468467A (en) 1995-11-21
EP0621491A2 (en) 1994-10-26
CA2119345A1 (en) 1994-10-24
KR100359898B1 (ko) 2003-01-10
HUT69795A (en) 1995-09-28
IL109115A0 (en) 1994-06-24
NO941485L (no) 1994-10-24
EP0621491B1 (en) 2002-07-24
DE69431016D1 (de) 2002-08-29
EP0621491A3 (en) 1995-06-07
IL109115A (en) 1997-07-13
HU9401166D0 (en) 1994-07-28
AU6061394A (en) 1994-10-27
CA2119345C (en) 1999-10-26
DE69431016T2 (de) 2003-03-27
ATE221208T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
FI941832A (fi) Menetelmiä NMR:llä havaittavien ksenobioottisten yhdisteiden in vivo määrittämiseksi
ATE125712T1 (de) 19f-markierte verbindungen zur verwendung als nmr-bilderzeugungs- und spektroskopiermittel.
ATE247282T1 (de) Verfahren zur identifizierung von hemmstoffe der produktion des beta-amyloidpeptids
DE69941429D1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
NO923821L (no) Diagnostiske midler
NO176839C (no) Ligander og fremgangsmåte for deres fremstilling, metallkomplekser dannet med disse ligander samt diagnostisk preparat og röntgenkontrastmiddel omfattende ovennevnte metallkomplekser
ATE394658T1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE69110098D1 (de) Teststreifen zur visuellen Bestimmung der Blutglucosekonzentration.
DE69114314D1 (de) Diagnostisches Verfahren zur Messung der Blutströmung.
DE68927438D1 (de) Verfahren zur herstellung monoklonaler antikörper mit hilfe eines keimfreien tieres
DE69424424D1 (de) Perfluoro-1h-1h-neopentyl-enthaltendes kontrastmittel und verfahren zu seiner verwendung
DE59009716D1 (de) Verfahren zur Prüfung der Qualität und der Qualitätsänderungen von biologischen Systemen und mit ihnen wechselwirkenden organisch-chemischen Verbindungen mittels Messung der ultraschwachen Photonenemission.
DE69127785D1 (de) System zur Bestimmung der Körperaktivität eines Patienten durch Messung der Blut-Sauerstoff-Sättigung
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE69530432D1 (de) Monoklonaler Antikörper gegen den Thrombin-Antithrombin Komplex-III und dessen Verwendung in immunoassays
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
ATE7049T1 (de) Verfahren zur bestimmung der gammaglutamyltranspeptidase.
DE68922686D1 (de) Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden.
TR199701744T1 (xx) Ha�arat m�cadele maddesi olarak s�bstit�e edilmi� 1,3-Dioksan-5-�lamino-Heterosayk�llar�.
SU1698676A1 (ru) Способ определени активности щитовидной железы
WO2000052465A3 (en) Biochemical markers of brain function
Darrah Physiological effects of blood flow through a region of induced atherosclerosis in the rat with emphasis on the effect of exercise on thrombosis and collateral vessel recruitment
IT8719808A0 (it) Agenti di contrasto per imaging nmr e relativo metodo diagnostico.
RU95121019A (ru) Способ определения степени магниточувствительности человека

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: BRACCO INTERNATIONAL B.V.